Be Vape Free Curriculum for Preventing Vaping

Overseen By Anabel Razo

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: Stanford University

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

10800 Participants Needed

Trial Summary

What is the purpose of this trial?

The Stanford Tobacco Prevention Toolkit is a free online curriculum developed for use by educators and health professionals in providing tobacco-specific prevention education to middle and high school students. A set of lessons focused on e-cigarette/vaping prevention education specifically is called the Be Vape Free curriculum. The aims of this study are to determine: (1) whether the Be Vape Free curriculum is effective in increasing middle and high school students' resistance to using tobacco and in decreasing positive attitudes towards and intentions to use e-cigarettes; (2) whether the Curriculum is effective in changing middle and high school students' actual use of tobacco; and (3) Examine heterogenous treatment effects identifying groups that benefit the most and those who do not benefit at all from the intervention.

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

What data supports the effectiveness of the Stanford Vaping Prevention curriculum as a treatment for preventing vaping?

A study involving high school students who participated in a 60-minute vaping prevention curriculum from the Stanford REACH Lab's Tobacco Prevention Toolkit showed significant improvements in their knowledge about e-cigarettes, their ability to refuse offers to vape, and their intentions to avoid vaping. This suggests that the curriculum can effectively change perceptions and behaviors related to vaping. ^{1 2 3 4 5}

How is the Be Vape Free Curriculum treatment different from other vaping prevention treatments?

The Be Vape Free Curriculum, part of the Stanford Vaping Prevention curriculum, is unique because it focuses on educating high school students about the harms of e-cigarettes and improving their refusal skills through a single 60-minute session. This approach is different from other treatments as it emphasizes changing perceptions and intentions to use e-cigarettes by directly addressing adolescents' misconceptions and providing practical skills to resist peer pressure. ^{1 5 6 7 8}

Research Team

Bonnie Halpern-Felsher, Ph.D.

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for middle and high school students who are currently receiving health education at schools that have chosen to participate in the study. There are no specific exclusion criteria, so all students in these settings can potentially join.

Inclusion Criteria

Middle school and high school students receiving health education at schools participating in the study

Exclusion Criteria

Not applicable.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pilot Phase

Stanford vaping prevention curriculum is administered as a pilot arm preceding the main experimental intervention

4-8 weeks

Randomized Phase

Participants receive either the Stanford vaping prevention curriculum or another curriculum/no vaping prevention education

12-24 weeks

Follow-up

Participants are monitored for changes in e-cigarette use and intention to use e-cigarettes

156 weeks

Treatment Details

Interventions

• Stanford Vaping Prevention curriculum

Trial Overview The trial is testing the 'Be Vape Free' curriculum from Stanford's Tobacco Prevention Toolkit. It aims to see if this online program helps reduce positive attitudes towards e-cigarettes, prevents tobacco use, and changes actual tobacco usage among students.

Participant Groups

Group I: Receives Stanford vaping prevention curriculum (randomized phase) Experimental Treatment 1 Intervention

Stanford vaping prevention curriculum is administered.

Group II: Receives Stanford vaping prevention curriculum (pilot phase) Experimental Treatment 1 Intervention

Stanford vaping prevention curriculum is administered as pilot arm preceding main experimental intervention.

Group III: Does not receive Stanford vaping prevention curriculum (randomized phase) Active Control 1 Intervention

Receives another curriculum or no vaping prevention education.

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials

2,527

Recruited

17,430,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+

References

1. United States pubmed.ncbi.nlm.nih.gov

Effects of a short school-based vaping prevention program for high school students. [2023]

2. United States pubmed.ncbi.nlm.nih.gov

Targeted Education for School Staff on Electronic Nicotine Delivery Systems: A Nurse Led Intervention. [2021]

3. United States pubmed.ncbi.nlm.nih.gov

Treatment of Adolescent e-Cigarette Use: Limitations of Existing Nicotine Use Disorder Treatment and Future Directions for e-Cigarette Use Cessation. [2022]

4. United States pubmed.ncbi.nlm.nih.gov

Examining the Efficacy of Project ECHO to Improve Clinicians' Knowledge and Preparedness to Treat Adolescent Vaping. [2023]

5. England pubmed.ncbi.nlm.nih.gov

Dissemination of CATCH My Breath, a middle school E-Cigarette prevention program. [2022]

6. United States pubmed.ncbi.nlm.nih.gov

Assessing Vaping Views, Usage, and Vaping-Related Education Among Medical Students: A Pilot Study. [2021]

7. United States pubmed.ncbi.nlm.nih.gov

Vaping-Know the Truth: Evaluation of an Online Vaping Prevention Curriculum. [2023]

8. England pubmed.ncbi.nlm.nih.gov

Effects of Smokefree Class Competition 1 year after the end of intervention: a cluster randomised controlled trial. [2017]